At a Glance
Dosage
Only in 2C-T-21
oral
| Level | Dose |
|---|---|
| Threshold | 5 mg |
| Light | 5–10 mg |
| Common | 10–12 mg |
| Strong | 12–15 mg |
| Heavy | 15 mg |
Only in 25B-NBOMe
insufflated
| Level | Dose |
|---|---|
| Threshold | 25 µg |
| Light | 50–200 µg |
| Common | 200–350 µg |
| Strong |
Duration
Only in 2C-T-21
oral
Onset
Peak
Offset
Afterglow
Onset: 1.5 hrs – 2 hrsPeak: 3 hrs – 4 hrsOffset: 2 hrs – 3 hrsAfterglow: 2 hrs – 4 hrs
Total: 10 hrs – 12 hrs
Only in 25B-NBOMe
sublingual
Peak
Offset
Effects
Safety
Interaction: 2C-T-21 + 25B-NBOMe
Low Risk & Synergy
Cross-tolerance exists; effects compound
2C-T-21 — Dangerous Interactions
No dangerous interactions recorded.
25B-NBOMe — Dangerous Interactions
No dangerous interactions recorded.
Frequently Asked Questions
What is the difference between 2C-T-21 and 25B-NBOMe?
2C-T-21 is classified as a Psychedelic (Substituted phenethylamines) while 25B-NBOMe is classified as a Psychedelic (Substituted phenethylamines). They share 30 effects in common, with 10 effects unique to 2C-T-21 and 7 unique to 25B-NBOMe.
Is it safe to combine 2C-T-21 and 25B-NBOMe?
The interaction between 2C-T-21 and 25B-NBOMe is classified as "Low Risk & Synergy". Cross-tolerance exists; effects compound Always research interactions thoroughly before combining any substances.
Which is stronger, 2C-T-21 or 25B-NBOMe?
2C-T-21 and 25B-NBOMe are typically administered via different routes, making a direct potency comparison difficult. They belong to different pharmacological profiles and should not be compared by dose alone.